Amanda Burkardt
Chief Executive Officer Phiogen Pharma
Seminars
Thursday 26th March 2026
Rewriting Chronic Disease with Dual-Action Phage Therapeutics
4:40 pm
- Rapid bacterial killing to shut down active disease
- Immune-driven prevention that blocks recurrence
- One platform addressing both infection and resistance
